Acorda Therapeutics (ACOR) Appoints Michael Rogers Chief Financial Officer; David Lawrence Named Chief of Business Operations
10/7/2013 7:36:20 AM
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Michael Rogers has joined the Company as Chief Financial Officer (CFO), effective October 7, 2013. He will assume responsibility for the Company’s Finance and Investor Relations departments. David Lawrence, M.B.A., who previously served as CFO, has been appointed Chief of Business Operations (CBO) and will be responsible for Technical Operations/Manufacturing, Project Management, Information Technology and Facilities Management.
Help employers find you! Check out all the jobs and post your resume.